A successful outcome of pregnancy in a patient with congenital antithrombin deficiency
Author(s) -
Mirjana Kovac,
Željko Miković,
Ljiljana Rakićević,
Snezana Srzentic,
Vesna Mandić,
Valentina Djordjević,
Dragica Radojković
Publication year - 2011
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp1102175k
Subject(s) - medicine , pregnancy , thrombophilia , antithrombin iii deficiency , placental abruption , obstetrics , antithrombin , preeclampsia , gestation , intrauterine growth restriction , low molecular weight heparin , apgar score , antiphospholipid syndrome , thrombosis , birth weight , heparin , surgery , genetics , biology
Presence of inherited thrombophilia is an additional risk factor for maternal thromboembolism and certain adverse pregnancy outcomes, including recurrent fetal loss, placental abruption, intrauterine growth restriction and early-onset severe preeclampsia. Pregnant women with thrombophilia, especially those with antithrombin (AT) deficiency, are at high risk of both kinds of complications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom